News and Announcements




Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma (HNSCC) that could be used to better determine appropriate treatment. The...

January 7, 2021   |   Read More

Activating point mutations in ErbB/Her2 receptor tyrosine kinases have an infamous role in promoting oncogenesis across several different cancers, including breast and lung.  Heterodimer activation of the ErbB2/ErbB3 oncogenic unit induces cancer cell proliferation via PI3K/AKT signaling...

December 14, 2020   |   Read More

In case you missed it, this final article (part 2 of 2) in the Investigator Spotlight Series, developed and written by Dr.

December 8, 2020   |   Read More

Latest Tweets